Alternative treatments for focal and segmental glomerular sclerosis

C. Ponticelli, P. Passerini

Research output: Contribution to journalArticle

Abstract

Corticosteroids represent the first therapeutic approach for patients with focal and segmantal glomerulosclerosis. What to do in patients who do not respond to corticostetoids is still uncertain. Cytotoxic agents have been tried. The results are usually poor when these drugs are given for short periods but almost half of patients may enter remission ir treatment is prolonged. Some decrease in proteinuria may be obtained with mycophenolav, mofetil but the available reports are still scanty and the follow ups are short. Cyclosporine has been largely used both in controlled and non controlled trials with favorable results. However, being the drug nephrotoxic caution should be recommended with its use. Plasma-exchange and lipopheresis may attempted in resistant cases.

Original languageEnglish
Pages (from-to)345-348
Number of pages4
JournalClinical Nephrology
Volume55
Issue number5
Publication statusPublished - 2001

Keywords

  • Corticosteroids
  • Cyclosporine
  • Cytotoxic agents
  • Focal glomerulosclerosis

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Alternative treatments for focal and segmental glomerular sclerosis'. Together they form a unique fingerprint.

  • Cite this

    Ponticelli, C., & Passerini, P. (2001). Alternative treatments for focal and segmental glomerular sclerosis. Clinical Nephrology, 55(5), 345-348.